Laigo Bio
PrivateLast Round
Seed
Mar 23, 2026
Total Funding Raised
$31.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Laigo Bio is a biotechnology company that develops bispecific antibody-based therapeutics for oncology and immunology using its proprietary SureTAC™ precision membrane protein degradation platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laigo Bio Comparables
Compare Laigo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlycoEra | 82% | |
| Avilar Therapeutics | 81% | |
| Johnson & Johnson | 80% |
Laigo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 23, 2026 | ||||
| Seed | Dec 4, 2025 | ||||
| Seed | Feb 8, 2022 |
Laigo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Horizons | Seed |
| ROM Utrecht Region | Seed |
| Oncode Institute | Seed |
| Biovance Capital Partners | Seed |
| Angelini Ventures | Seed |
| Cancer Research Horizons | Seed |
| Eurazeo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 22% QoQ, from 18 to 22 employees.
- Jun 23, 2026
Grew 33% QoQ from 15 to 20 employees.
Laigo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Laigo Bio's valuation, stock price, and market status.
Is Laigo Bio a public or private company?
Laigo Bio is a private company.
What is the current stock price of Laigo Bio?
Laigo Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Laigo Bio worth (valuation)?
Valuation information for Laigo Bio is not publicly available.
Can I buy Laigo Bio stock?
Laigo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Laigo Bio's last funding round?
Laigo Bio's most recent funding round was Seed on March 23, 2026.
Who are the main investors in Laigo Bio?
Key investors in Laigo Bio include Biovance Capital Partners, Kurma Partners, Curie Capital.
Will Laigo Bio IPO soon?
No public IPO plans have been announced for Laigo Bio.
How can I track Laigo Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Laigo Bio's secondary market activity and sign up for updates.